home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  December 22, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries

VIRCELL, S.L.

Parque Tecnologico de la Salud, Avicena 8
Granada, 18006
Spain

Phone: +34 958 44 12 64
Fax: +34 958 51 07 12
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Vircell, established in 1991, is a leading developer of ready-to-use kits for the diagnosis of infectious diseases with successful operations in over 80 countries.

From the beginning, we focus on producing reagents of the highest quality alongside providing accessible technical staff to ensure prompt and personal assistance in the use of these reagents.

Vircell, highly specialized in research & development, offers complete diagnostics solutions by means of different techniques: ELISA, CLIA, IFA, DFA, rapid tests, molecular biology and unique in-house developments.

The in-house production of all the antigens needed for the development of its kits enables Vircell to work with independence from external suppliers. This peculiarity makes it a flexible company able to guarantee the quality of its products. The reliability of its kits is the result of a strict quality control according to international standards. All distributed tests are validated and CE-marked complying with the European directive 98/79/CE. Vircell is certified ISO 13485 and ISO 9001 AENOR and is involved in the process of implementation of GMP standards.



Selected Categories:
Product Company   Service Company
Diagnostics
- Immunoassay
- in vitro
- Medical
Contract
- Production
- Research

Last update of this entry: October 29, 2024

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.